Dilated cardiomyopathy, Heart failure with reduced ejection fraction, Angiotensin‐converting enzyme inhibitor, Angiotensin II receptor blocker, Diseases of the circulatory (Cardiovascular) system, RC666-701

Abstract Aims Angiotensin‐converting enzyme inhibitors (ACEis) or angiotensin II receptor blockers (ARBs) have been shown to be associated with recovery of cardiac function in patients with dilated cardiomyopathy (DCM). The aim of this study was to assess comparative effectiveness of ACEis vs. ARBs on recovery of left ventricular ejection fraction (LVEF) among patients with DCM. Methods and results We analysed the clinical personal records of DCM, a national database of the Japanese Ministry of Health, Labour and Welfare, from 2003 to 2014. Patients with LVEF